Roles
- Professor & Chair, Department of Medicine
- Kathleen & Stanley Glaser Distinguished Chair in Medicine
- Rabbi Morris I. Esformes Endowed Chair in Medicine and Endocrinology
- Chief Medical Officer, Ambulatory Services
-
Biography
Dr. Roy Weiss is the Chairman of the Department of Medicine and the Kathleen and Stanley Glaser Distinguished Chair in Medicine at the University of Miami Miller School of Medicine. He is also the Rabbi Morris I. Esformes Endowed Professor. As Chairman of the Department of Medicine (DOM) he is responsible for the research and scholarly activity and clinical enterprise of over 350 full time faculty and 850 voluntary faculty with a budget including $210M in revenue and expenses.
Dr. Weiss’ leadership at University of Miami these past 6 years as well as the past 29 years at the University of Chicago has been devoted to providing the latest innovations to health care, discovery science and education. As a physician scientist his career has been devoted to diagnosis and treatment of genetic diseases of the thyroid with the discovery of new genes and mechanisms of thyroid hormone action and disease. He has been director of an NIH funded Clinical Research Center for more than 10 years. As an investigator who has been R01 funded, and supported by a K-24 to mentor junior physician scientists he has also mentored Ph.D. students as well as fellows and housestaff. He is the PI of a U54 on Personalized Medicine in Health Disparities.
Dr. Weiss is the immediate past President of the Central Society for Translational and Clinical Research and co-edited the only textbook, now in its second edition on the genetic basis of endocrine disease, 2nd Edition Genetic Diagnosis of Endocrine Diseases. He has published over 175 papers. He is a fellow in the American College of Physicians, The American College of Endocrinology and the American Academy of Pediatrics. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Copyrights & Patents
Articles & News
UHealth Named a 2026 Vizient Ambulatory Quality and Accountability Top Performer
UHealth’s Commitment to Exceptional Patient Care Fuels Historic Rise in U.S. News Rankings
A “Doctor’s Doctor” Lifts Off into Retirement
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
MCT8 deficiency (that is also known as Allan-Herndon-Dudley syndrome) is a rare X-linked inherited disorder of brain development that causes severe intellectual disability and problems with movement. This condition, which occurs almost exclusively in males, disrupts development from before birth. There is no sucking reflex and the child has marked hypotonia. Developmentally, unlike normal infants, affected males are unable to turn over from belly to back. Individuals with identical mutations have identical phenotypes and all individuals, regardless of the phenotype have severe neuropsychological impairment. Diagnosis is confirmed by demonstration of a mutation in the MCT8 gene (1,2).
- Principal Investigator: Roy Weiss
- Study Phase: N/A
- Enrollment Status: Open
-
This study will utilize the thyrotropin-releasing hormone (TRH), a drug used for diagnosing and evaluating patients with certain thyroid gland abnormalities in the USA.
- Principal Investigator: Roy Weiss
- Study Phase: Other
- Enrollment Status: Open